$CRCW Cashflow Statement | Understand Stock

$CRCW

$0.00 +$0.00 (0.0%) Close

Financial Statements

In USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net (loss)
Adjustments to reconcile net loss to net cash (used in) operations:
Amortization
Depreciation and amortization
Share-based compensation
Change in derivative liability
Debt discount for warrants
Gain on the forgiveness of debt
Warrants issued for financing fee
Gain on the extinguishment of debt
Common stock issued as a financing fee
Cryptocurrency
Amortization of note discount
Impairment Charge
Loss on disposal of equipment
Accounts receivable
Prepaid expenses
Change in operating assets and liabilities:
Accounts payable and accrued expenses
Other liabilities

Net cash (used in) operating activities
Purchase of BTA subsidiary
Purchase of computer equipment
Net cash (used in) investing activities
Cash flows from financing activities:
Proceeds from loans payable
Payment of notes payable
Proceeds from the issuance of convertible notes
Proceeds from issuance of notes payable
Proceeds from common stock issuance
Net cash provided by financing activities

Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the period
Cash and cash equivalents at the end of the period
Common Stock issued for BTA acquisition
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Common stock issued to reduce convertible debt
Common stock issued to reduce accrued liabilities

Comments